Ironwood Pharmaceuticals (IRWD) Profit After Tax (2010 - 2026)

Ironwood Pharmaceuticals has disclosed Profit After Tax across 17 years of filings, most recently posting $40.8 million for Q1 2026.

• Profit After Tax for Q1 2026 came in at $40.8 million, up 209.06% year-over-year; the trailing twelve-month figure through Mar 2026 was $102.2 million (up 415.9% YoY), and the FY2025 annual result was $24.0 million, up 2629.2% from the prior year.
• Profit After Tax came in at $40.8 million for Q1 2026 at Ironwood Pharmaceuticals, up from -$2.3 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $50.3 million in Q3 2022 to a low of -$1.1 billion in Q2 2023.
• The 5-year median for Profit After Tax is $15.3 million (2023), against an average of -$44.8 million.
• Across the five-year window, Profit After Tax sank 2964.58% in 2023 and surged 2844.07% in 2025, its largest moves.
• Ironwood Pharmaceuticals' Profit After Tax stood at $48.9 million in 2022, then slumped by 102.22% to -$1.1 million in 2023, then soared by 307.54% to $2.3 million in 2024, then slumped by 200.89% to -$2.3 million in 2025, then soared by 1891.43% to $40.8 million in 2026.
• The last three Profit After Tax figures came in at $40.8 million (Q1 2026), -$2.3 million (Q4 2025), and $40.1 million (Q3 2025), per Business Quant data.